Back to search

Article

Molecular pharmacodynamics of amoxicillin-clavulanic acid against Escherichia coli

2025-12-10

Abstract excerpt

<title>Abstract</title> <p> Amoxicillin-clavulanic acid (AMX-CLV) is a widely used oral β-lactam/β-lactamase inhibitor combination against <italic>Escherichia coli</italic> . Clinical success is largely confined to urinary tract infections. The mechanistic basis for this site-specific efficacy remains unclear. Using a hollow-fibre infection model to replicate human plasma and urinary pharmacokinetics, we show...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
54cb3b64-8006-5f8b-afec-819f870e4217
DOI
10.21203/rs.3.rs-8148425/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular pharmacodynamics of amoxicillin-clavulanic acid against Escherichia coliDOI 10.21203/rs.3.rs-8148425/v1
Select a neighboring publication to make it the new centre.